IGC Pharma (IGC) Market Capitalization (2010 - 2026)

IGC Pharma (IGC) has reported Market Capitalization for 17 consecutive years, with $26.0 million the latest figure, recorded in Q1 2026.

• On a quarterly basis, Market Capitalization rose 12.72% year-over-year to $26.0 million in Q1 2026; TTM through Mar 2026 was $26.0 million, a 12.72% increase from a year earlier, with the FY2026 full-year figure at $26.0 million, up 12.72% from the prior year.
• Market Capitalization was $26.0 million for Q1 2026 at IGC Pharma, roughly flat from $25.9 million in the prior quarter.
• Over five years, Market Capitalization peaked at $48.4 million in Q1 2022 and troughed at $16.5 million in Q2 2023.
• A 5-year average of $26.4 million and a median of $25.9 million in 2025 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization slumped 69.71% in 2022 and jumped 98.39% in 2024, its largest moves.
• Over 5 years, Market Capitalization stood at $16.9 million in 2022, then grew by 5.73% to $17.9 million in 2023, then surged by 47.19% to $26.3 million in 2024, then slipped by 1.52% to $25.9 million in 2025, then climbed by 0.41% to $26.0 million in 2026.
• The last three Market Capitalization figures came in at $26.0 million (Q1 2026), $25.9 million (Q4 2025), and $38.3 million (Q3 2025), per Business Quant data.